Letter to the Editor
Cangrelor as antiplatelet bridging therapy in non-cardiac surgery after percutaneous coronary intervention – First-time use in Portugal
Cangrelor como terapêutica antiplaquetária de bridging na cirurgia não cardíaca após intervenção coronária percutânea – Primeira utilização em Portugal
Inês Fialhoa,
, João B. Augustoa,b, Susana Fevereiroc, Miguel B. Santosa, Sérgio Bravo Baptistad, David Roquea
Corresponding author
a Cardiology Department, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal
b Institute of Cardiovascular Science, University College London, UK
c Transfusion Medicine Department, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Carnaxide, Portugal
d University Clinic of Cardiology, Faculty of Medicine at University of Lisbon, Lisboa, Portugal
Read
4886
Timeswas read the article
1682
Total PDF
3204
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 73 | 23 | 96 |
| 2025 5 | 297 | 50 | 347 |
| 2025 4 | 144 | 53 | 197 |
| 2025 3 | 159 | 51 | 210 |
| 2025 2 | 84 | 32 | 116 |
| 2025 1 | 95 | 46 | 141 |
| 2024 12 | 98 | 44 | 142 |
| 2024 11 | 83 | 65 | 148 |
| 2024 10 | 70 | 42 | 112 |
| 2024 9 | 112 | 50 | 162 |
| 2024 8 | 71 | 61 | 132 |
| 2024 7 | 66 | 47 | 113 |
| 2024 6 | 64 | 33 | 97 |
| 2024 5 | 71 | 37 | 108 |
| 2024 4 | 60 | 50 | 110 |
| 2024 3 | 83 | 30 | 113 |
| 2024 2 | 41 | 36 | 77 |
| 2024 1 | 64 | 45 | 109 |
| 2023 12 | 52 | 40 | 92 |
| 2023 11 | 69 | 53 | 122 |
| 2023 10 | 63 | 37 | 100 |
| 2023 9 | 49 | 35 | 84 |
| 2023 8 | 53 | 35 | 88 |
| 2023 7 | 64 | 55 | 119 |
| 2023 6 | 59 | 36 | 95 |
| 2023 5 | 52 | 38 | 90 |
| 2023 4 | 43 | 24 | 67 |
| 2023 3 | 64 | 23 | 87 |
| 2023 2 | 58 | 33 | 91 |
| 2023 1 | 40 | 23 | 63 |
| 2022 12 | 55 | 24 | 79 |
| 2022 11 | 73 | 41 | 114 |
| 2022 10 | 74 | 44 | 118 |
| 2022 9 | 85 | 59 | 144 |
| 2022 8 | 123 | 43 | 166 |
| 2022 7 | 93 | 49 | 142 |
| 2022 6 | 147 | 80 | 227 |
| 2022 5 | 44 | 29 | 73 |
| 2022 4 | 57 | 39 | 96 |
| 2022 3 | 52 | 47 | 99 |
Show all
